You have 9 free searches left this month | for more free features.

sapanisertib

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

Recruiting
  • Leptomeningeal Neoplasm
  • +6 more
  • Sapanisertib
  • Telaglenastat Hydrochloride
  • Duarte, California
  • +6 more
Dec 29, 2022

NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • sapanisertib
  • Davis, California
  • +13 more
Nov 7, 2022

Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory

Completed
  • Recurrent Lung Squamous Cell Carcinoma
  • Stage IV Lung Squamous Cell Carcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 16, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • Nivolumab
  • Sapanisertib
  • (no location specified)
May 24, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)

Completed
  • Endometrial Neoplasms
  • Birmingham, Alabama
  • +77 more
Oct 28, 2021

Advanced Solid Tumors Trial in United States (Sapanisertib)

Completed
  • Advanced Solid Tumors
  • Sapanisertib
  • Sarasota, Florida
  • +4 more
Feb 18, 2020

Breast Cancer Trial in Belgium, France, United States (Sapanisertib, Fulvestrant, Exemestane)

Completed
  • Breast Cancer
  • Sapanisertib
  • +2 more
  • Los Angeles, California
  • +39 more
Dec 16, 2020

Breast Tumors Trial in Spain, United States (Fulvestrant, Sapanisertib)

Completed
  • Breast Neoplasms
  • Mobile, Alabama
  • +52 more
Nov 20, 2020

Non-hematologic Malignancy Trial in United States (Sapanisertib, Paclitaxel)

Completed
  • Non-hematologic Malignancy
  • Scottsdale, Arizona
  • +4 more
Feb 14, 2020

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022